Sean Brynjelsen, CEO of Eton Pharmaceuticals, recently sold approximately $6.08 million worth of his company's stock. This significant insider transaction could signal a shift in executive confidence.
Eton Pharmaceuticals CEO Sells $6.08 Million in Company Stock
|1 min read
Eton PharmaceuticalsInsider SellingCEO TransactionsPharmaceuticalsExecutive Activity